Skip to main content
. 2018 Mar 21;15(5):8072–8078. doi: 10.3892/ol.2018.8310

Table II.

Five-year outcomes as a function of POSTN expression.

Patients with POSTN status (%)

Clinical outcome Negative Positive P-value
Local recurrence-free survival 95.8 89.0 0.017
Distant metastasis-free survival 92.3 79.1 0.001
Overall survival 93.5 80.2 0.001

POSTN, periostin.